Corcept Therapeutics Incorporated Detailed Financials

Full historical quarterly statements

Metric	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	164.9M	202.1M	207.6M	194.4M	157.2M	181.9M	182.5M	163.8M
Cost of Goods Sold	2.9M	2.5M	4.6M	3.4M	2.4M	3.0M	2.9M	2.5M
Gross Profit	162.0M	199.6M	203.0M	191.0M	154.8M	178.9M	179.7M	161.3M
R&D Expenses	66.3M	64.9M	68.8M	60.5M	60.7M	70.3M	59.3M	58.7M
Operating Expenses	211.6M	195.1M	192.8M	164.3M	151.4M	153.7M	133.1M	125.7M
Operating Income	-49.6M	4.5M	10.2M	26.7M	3.4M	25.3M	46.6M	35.6M
Other Income / Gains	4.9M	5.4M	5.0M	5.0M	6.2M	6.7M	6.3M	6.0M
Net Income	-31.2M	24.3M	19.7M	35.1M	20.5M	30.4M	46.7M	35.5M
EPS (Diluted)	-0.30	0.23	0.19	0.33	0.19	0.29	0.45	0.34
Reported Currency	USD	USD	USD	USD	USD	USD	USD	USD
Gross Profit Ratio	0.983	0.987	0.978	0.982	0.985	0.984	0.984	0.985
General And Administrative Expenses	0	0	0	0	0	0	0	0
Selling And Marketing Expenses	0	0	0	0	0	0	0	0
Selling General And Administrative Expenses	145.4M	130.2M	124.0M	103.9M	90.7M	83.4M	73.7M	66.9M
Other Expenses	0	1.00	0	0	0	0	0	500K
Cost And Expenses	214.5M	197.6M	197.4M	167.8M	153.8M	156.6M	135.9M	128.2M
Interest Income	0	0	0	0	0	6.7M	6.3M	6.0M
Interest Expense	0	0	0	0	0	0	0	0
Depreciation And Amortization	0	482K	477K	469K	462K	460K	499K	257K
Ebitda	-49.6M	5.0M	10.7M	27.1M	3.9M	25.7M	47.1M	41.9M
Ebitdaratio	-0.301	0.025	0.052	0.14	0.025	0.141	0.258	0.256
Operating Income Ratio	-0.301	0.022	0.049	0.137	0.022	0.139	0.255	0.217
Income Before Tax	-44.7M	9.9M	15.2M	31.7M	9.6M	32.0M	52.9M	41.6M
Income Before Tax Ratio	-0.271	0.049	0.073	0.163	0.061	0.176	0.29	0.254
Income Tax Expense	-13.5M	-14.4M	-4.4M	-3.5M	-10.9M	1.2M	5.7M	6.1M
Net Income Ratio	-0.189	0.12	0.095	0.181	0.131	0.167	0.256	0.217
Epsdiluted	-0.30	0.20	0.16	0.29	0.17	0.26	0.41	0.32
Weighted Average Shs Out	104.4M	103.7M	103.5M	104.1M	104.1M	103.6M	103.4M	103.1M
Weighted Average Shs Out Dil	104.4M	119.9M	119.4M	120.5M	119.8M	118.5M	113.7M	111.2M